UBE2QL1
Ubiquitin-conjugating enzyme E2Q-like protein 1
Also known as: FLJ25076, U2QL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A1L167
- Gene
- UBE2QL1
- Ensembl
- ENSG00000215218
- Chromosome
- 5
- Canonical length
- 161 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
Enables ubiquitin conjugating enzyme activity. Predicted to be involved in protein polyubiquitination. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
161 residues, UniProt reviewed canonical sequence.
>A1L167|UBE2QL1
1 MKELQDIARL SDRFISVELV DESLFDWNVK LHQVDKDSVL WQDMKETNTE FILLNLTFPD
61 NFPFSPPFMR VLSPRLENGY VLDGGAICME LLTPRGWSSA YTVEAVMRQF AASLVKGQGR
121 ICRKAGKSKK SFSRKEAEAT FKSLVKTHEK YGWVTPPVSD GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2QL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 38 nTPM
- cerebellum: 34 nTPM
- cerebral cortex: 29 nTPM
- retina: 26 nTPM
- hippocampal formation: 19 nTPM
- tongue: 13 nTPM
Single-cell type
- rod photoreceptor cells: 193 nCPM
- renal collecting duct intercalated cells: 135 nCPM
- cone photoreceptor cells: 81 nCPM
- pancreatic islet cells: 59 nCPM
- myonuclei: 58 nCPM
- brain excitatory neurons: 55 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 46 nTPM
- white matter: 36 nTPM
- hippocampal formation: 36 nTPM
- cerebellum: 33 nTPM
- basal ganglia: 28 nTPM
- pons: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0.68
- gnomAD missense Z
- 2.14
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2QL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2QL1 as an antibody target. Whether an autoantibody or antibody against UBE2QL1 could matter depends on whether native UBE2QL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2QL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2QL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...